All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

AstraZeneca PLC revenue reports

AstraZeneca PLC financial reports, AstraZeneca PLC annual revenue in 2024. When does AstraZeneca PLC report revenue?
Add to widgets
Added to widgets

AstraZeneca PLC total revenue, net income and dynamics of changes in US dollar today

Net revenue of AstraZeneca PLC on 30/06/2021 amounted to 8 220 000 000 $. The dynamics of AstraZeneca PLC net revenue increased by 900 000 000 $ from the last reporting period. The dynamics of net income of AstraZeneca PLC has changed by -1 011 000 000 $ in recent years. The financial schedule of AstraZeneca PLC consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. AstraZeneca PLC financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. A graph of the value of all AstraZeneca PLC assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 8 220 000 000 $ +41.16 % ↑ 550 000 000 $ +323.08 % ↑
31/03/2021 7 320 000 000 $ +33.31 % ↑ 1 561 000 000 $ +163.24 % ↑
31/12/2020 7 410 000 000 $ +15.47 % ↑ 1 012 000 000 $ -2.128 % ↓
30/09/2020 6 578 000 000 $ +2.68 % ↑ 648 000 000 $ +116.72 % ↑
30/09/2019 6 406 000 000 $ - 299 000 000 $ -
30/06/2019 5 823 000 000 $ - 130 000 000 $ -
31/03/2019 5 491 000 000 $ - 593 000 000 $ -
31/12/2018 6 417 000 000 $ - 1 034 000 000 $ -
30/09/2018 5 340 000 000 $ - 431 000 000 $ -
30/06/2018 5 155 000 000 $ - 350 000 000 $ -
Show:
to

AstraZeneca PLC financial report charts

Dates of AstraZeneca PLC finance reports: 30/06/2018, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of AstraZeneca PLC for today is 30/06/2021. Gross profit AstraZeneca PLC is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit AstraZeneca PLC is 6 029 000 000 $

AstraZeneca PLC quarterly report dates

Cost of revenue AstraZeneca PLC is the total cost of producing and distributing of products and services of a company. Cost of revenue AstraZeneca PLC is 2 191 000 000 $ Total revenue AstraZeneca PLC refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue AstraZeneca PLC is 8 220 000 000 $ Operating income AstraZeneca PLC is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income AstraZeneca PLC is 1 127 000 000 $

Net income AstraZeneca PLC is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income AstraZeneca PLC is 550 000 000 $ Current assets AstraZeneca PLC is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets AstraZeneca PLC is 27 274 000 000 $ Total assets AstraZeneca PLC refers to the total amount of assets owned by a person or entity. Total assets AstraZeneca PLC is 73 641 000 000 $

30/06/2021 31/03/2021 31/12/2020 30/09/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
6 029 000 000 $ 5 463 000 000 $ 5 894 000 000 $ 5 217 000 000 $ 5 125 000 000 $ 4 774 000 000 $ 4 400 000 000 $ 5 135 000 000 $ 4 209 000 000 $ 4 166 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 191 000 000 $ 1 857 000 000 $ 1 516 000 000 $ 1 361 000 000 $ 1 281 000 000 $ 1 049 000 000 $ 1 091 000 000 $ 1 282 000 000 $ 1 131 000 000 $ 989 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
8 220 000 000 $ 7 320 000 000 $ 7 410 000 000 $ 6 578 000 000 $ 6 406 000 000 $ 5 823 000 000 $ 5 491 000 000 $ 6 417 000 000 $ 5 340 000 000 $ 5 155 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 127 000 000 $ 1 169 000 000 $ 546 000 000 $ 1 282 000 000 $ 898 000 000 $ 850 000 000 $ 1 200 000 000 $ 489 000 000 $ 725 000 000 $ 855 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
550 000 000 $ 1 561 000 000 $ 1 012 000 000 $ 648 000 000 $ 299 000 000 $ 130 000 000 $ 593 000 000 $ 1 034 000 000 $ 431 000 000 $ 350 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 829 000 000 $ 1 700 000 000 $ 1 881 000 000 $ 1 481 000 000 $ 1 328 000 000 $ 1 326 000 000 $ 1 232 000 000 $ 1 474 000 000 $ 1 242 000 000 $ 1 331 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
7 093 000 000 $ 6 151 000 000 $ 6 864 000 000 $ 5 296 000 000 $ 5 508 000 000 $ 4 973 000 000 $ 4 291 000 000 $ 5 928 000 000 $ 4 615 000 000 $ 4 300 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
27 274 000 000 $ 18 735 000 000 $ 19 544 000 000 $ 18 166 000 000 $ 13 520 000 000 $ 15 219 000 000 $ 13 649 000 000 $ 15 591 000 000 $ 13 108 000 000 $ 12 449 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
73 641 000 000 $ 64 926 000 000 $ 66 729 000 000 $ 64 112 000 000 $ 58 906 000 000 $ 61 889 000 000 $ 61 055 000 000 $ 60 651 000 000 $ 61 443 000 000 $ 61 344 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
15 567 000 000 $ 7 636 000 000 $ 7 832 000 000 $ 8 072 000 000 $ 3 967 000 000 $ 5 428 000 000 $ 4 136 000 000 $ 4 831 000 000 $ 3 420 000 000 $ 2 978 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 14 776 000 000 $ 16 034 000 000 $ 18 256 000 000 $ 16 292 000 000 $ 15 248 000 000 $ 17 201 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 45 237 000 000 $ 46 818 000 000 $ 49 026 000 000 $ 46 607 000 000 $ 47 906 000 000 $ 47 072 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 76.80 % 75.65 % 80.30 % 76.84 % 77.97 % 76.73 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
15 676 000 000 $ 14 430 000 000 $ 15 622 000 000 $ 12 195 000 000 $ 12 164 000 000 $ 13 548 000 000 $ 10 483 000 000 $ 12 468 000 000 $ 11 936 000 000 $ 12 645 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 1 103 000 000 $ 878 000 000 $ -387 000 000 $ 2 224 000 000 $ 469 000 000 $ 65 000 000 $

Last revenue report of AstraZeneca PLC was 30/06/2021. According to last financial report total revenue in AstraZeneca PLC was 8 220 000 000 US dollar and changed by +41.16% since last year. Net income in AstraZeneca PLC was 550 000 000 $ in last quartal, net income changes to +323.08%.

Current cash AstraZeneca PLC - the sum of all of the cash a company has on the date of report. Current cash AstraZeneca PLC is 15 567 000 000 $

AstraZeneca PLC stocks data

AstraZeneca PLC financials